(XSX7) Xtrackers Stoxx Europe 600 - Ratings and Ratios
Equity, Europe, Large Cap, Broad Market, 600
Dividends
| Dividend Yield | 2.62% |
| Yield on Cost 5y | 3.95% |
| Yield CAGR 5y | 21.05% |
| Payout Consistency | 97.5% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 9.50% |
| Value at Risk 5%th | 16.5% |
| Relative Tail Risk | 5.39% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.14 |
| Alpha | 15.20 |
| CAGR/Max DD | 0.96 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.490 |
| Beta | 0.137 |
| Beta Downside | 0.303 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.32% |
| Mean DD | 1.89% |
| Median DD | 1.34% |
Description: XSX7 Xtrackers Stoxx Europe 600 November 30, 2025
The Xtrackers Stoxx Europe 600 UCITS ETF 1D (XETRA: XSX7) tracks the Morningstar DM Eur TME Net Return index, offering exposure to roughly 600 large-cap European equities across 18 countries.
Key facts: the fund is domiciled in Germany, classified as a Europe Large-Cap Blend Equity ETF, and trades under the ticker XSX7. Its net asset value (NAV) typically reflects the aggregate performance of the Stoxx Europe 600, which in Q2 2024 posted a year-to-date return of about 4.2 % and a dividend yield near 2.8 %.
Drivers to watch: (1) Eurozone monetary policy – the European Central Bank’s stance on interest rates directly impacts valuation multiples for the index’s financial and consumer-discretionary sectors. (2) Energy transition – the Stoxx Europe 600 has a higher weighting in utilities and industrials than the S&P 500, making it sensitive to EU climate-policy incentives and carbon-price trends. (3) Earnings growth – recent consensus estimates suggest average earnings-per-share growth of 5-6 % for the index’s constituents in 2025, outpacing the broader European GDP forecast of ~1.5 %.
If you want a data-rich, side-by-side comparison of XSX7’s risk-adjusted performance against peers, the ValueRay platform provides interactive charts and the latest analytics – a useful next step before making a allocation decision.
What is the price of XSX7 shares?
Over the past week, the price has changed by +2.22%, over one month by +4.72%, over three months by +6.57% and over the past year by +21.54%.
Is XSX7 a buy, sell or hold?
What are the forecasts/targets for the XSX7 price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 106.7 | 13.8% |
XSX7 Fundamental Data Overview January 07, 2026
Market Cap EUR = 900.9m (900.9m EUR * 1.0 EUR.EUR)
Beta = 0.0
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 900.9m EUR (900.9m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 900.9m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 900.9m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.52% (E(900.9m)/V(900.9m) * Re(6.52%) + (debt-free company))
Discount Rate = 6.52% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)